<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04686890</url>
  </required_header>
  <id_info>
    <org_study_id>KIA 2020/96</org_study_id>
    <nct_id>NCT04686890</nct_id>
  </id_info>
  <brief_title>Comparison of Erector Spinae Plane Block and Intravenous Analgesic in Nefrectomy</brief_title>
  <official_title>Erector Spinae Plane Block for Nefrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kocaeli University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kocaeli University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The efficacy of erector spinae plane block versus intravenous analgesics compared relate to&#xD;
      the morphine consumptions&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing elective nefrectomy were enrolled. Patients divided into two groups with&#xD;
      a sealed envelope technique to ESP+ pca morphine group or iv analgesic + pca morphine group.&#xD;
      All patients will premedicated. then esp will applied to one group before surgery at the&#xD;
      preoperative care unit by the same anesthesiologist. The other group will receive intravenous&#xD;
      tramadol 1 mg/kg + NSAID 1 ampule + parol 10 mg/ kg + ondansetron 4 mg bolus. Ä°ntravenous&#xD;
      morphine pca with a concentration of 0.5 mg/cc were applied. And administered 1 mg boluses&#xD;
      every 15 minutes lock time and 4 hour limit as 4 mg arranged. An anesthesia nurse who is&#xD;
      responsible of all pcas' in the hospital was recorded the variables of these patients in the&#xD;
      service&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 30, 2020</start_date>
  <completion_date type="Actual">March 10, 2021</completion_date>
  <primary_completion_date type="Actual">March 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative intravenous morphine patient controlled analgesia consumption</measure>
    <time_frame>during postoperatively</time_frame>
    <description>morphine consumptions were recorded till 24 th hour postoperatively</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peroperative remifentanyl consumption</measure>
    <time_frame>Peroperatively</time_frame>
    <description>Amount of Remifentanyl consumption recorded</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual analog rating scores</measure>
    <time_frame>during postoperative surgery</time_frame>
    <description>pain scores were recorded during surgery</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">46</enrollment>
  <condition>Regional Anesthesia Morbidity</condition>
  <condition>Nephrectomy</condition>
  <arm_group>
    <arm_group_label>postoperative opiod (morphine) consumption</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patient-controlled analgesia (15 minutes. lock time, 2 ml bolus= total 1 mg morphine intravenously, limited to maximum 4 bolus / per hour )</description>
  </arm_group>
  <arm_group>
    <arm_group_label>peroperative continuous opioid (remifentanil) consumption</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>continuous remifentanil infusion was given during the whole procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>postoperative numerated rating scale</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>at the 1, 3, 6, 12 and 24 th hour postoperatively - numerated rating scale score was evaluated and recoded as 0= no pain (better), 10: unbearable pain (worse)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>erector spinea plane block administered preoperative open nephrectomy</intervention_name>
    <description>erector spinae plane block applied in this group before open nephrectomy</description>
    <arm_group_label>peroperative continuous opioid (remifentanil) consumption</arm_group_label>
    <arm_group_label>postoperative numerated rating scale</arm_group_label>
    <arm_group_label>postoperative opiod (morphine) consumption</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>intravenous analgesic ( 1 mg/kg tramadol + non-steroid antiinflamatuar paracetamol )drug + 10 mg.kg</intervention_name>
    <description>intarvenous analgesic administered in this group for analgesia end of the open nephrectomy</description>
    <arm_group_label>peroperative continuous opioid (remifentanil) consumption</arm_group_label>
    <arm_group_label>postoperative numerated rating scale</arm_group_label>
    <arm_group_label>postoperative opiod (morphine) consumption</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:18-65 years age&#xD;
&#xD;
          -  ASA I-II&#xD;
&#xD;
          -  undergoing elective nephrectomy&#xD;
&#xD;
        Exclusion Criteria:- ASA&gt;3&#xD;
&#xD;
          -  heart disease&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  lung disease&#xD;
&#xD;
          -  scoliosis&#xD;
&#xD;
          -  bleeding disorder&#xD;
&#xD;
          -  infection at the manipulation side&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zehra Arslan</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kocaeli University Medical Faculty</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kocaeli University Medical Faculty</name>
      <address>
        <city>Kocaeli</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>December 7, 2020</study_first_submitted>
  <study_first_submitted_qc>December 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 29, 2020</study_first_posted>
  <last_update_submitted>March 14, 2021</last_update_submitted>
  <last_update_submitted_qc>March 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kocaeli University</investigator_affiliation>
    <investigator_full_name>Zehra Ipek ARSLAN</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>nefrectomy</keyword>
  <keyword>erector spinea plane block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Tramadol</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

